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Crystal Structure of Constitutive Endothelial
Nitric Oxide Synthase: A Paradigm for Pterin
Function Involving a Novel Metal Center
Griffith and Stuehr, 1995; Masters et al., 1996). The neu-
ronal (nNOS) and endothelial NOS (eNOS) are constitu-
tive with posttranslational regulation of enzyme activity.
The inducible isoform (iNOS) is produced in response
to certain stimuli (e.g., cytokines) and is regulated mostly
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by eNOS has been shown to be antiatherogenic and
critical for angiogenesis. Therefore, isoform-specific
drugs are required to inhibit NO production by nNOS
Summary and iNOS under pathological conditions without hinder-
ing NO generation by eNOS. In addition, upregulation
Nitric oxide, a key signaling molecule, is produced of eNOS via suitable activators holds a significant thera-
by a family of enzymes collectively called nitric oxide peutic potential in controlling cardio- and cerebrovascu-
synthases (NOS). Here, we report the crystal structure lar disorders.
of the heme domain of endothelial NOS in tetrahy- Both iNOS and nNOS are cytosolic enzymes, while
eNOS is membrane bound (Pollock et al., 1991). eNOSdrobiopterin (H4B)-free and -bound forms at 1.95 AÊ and
also is unique in that it is targeted to the caveolae (Shaul1.9 AÊ resolution, respectively. In both structures a zinc
et al., 1996) of vascular endothelial cells, where it is dy-ion is tetrahedrally coordinated to pairs of symmetry-
namically regulated by interactions with caveolin (GarcõÂa-related cysteine residues at the dimer interface. The
CardenÄ a et al., 1997). All three NOS isoforms exhibit anphylogenetically conserved Cys-(X)4-Cys motif and its
absolute requirement for (1'R, 2'S, 6R)-5,6,7,8-tetrahy-strategic location establish a structural role for the
drobiopterin (H4B) as a cofactor to function (Kwon et al.,metal center in maintaining the integrity of the H4B-
1989; Tayeh and Marletta, 1989; Kaufman, 1997), andbinding site. The unexpected recognition of the sub-
only reduced pterin can sustain catalysis. Despite exten-strate, L-arginine, at the H4B site indicates that this
sive biochemical studies, the role of pterin function insite is poised to stabilize a positively charged pterin
NOS remains a mystery (Hemmens and Mayer, 1997).ring and suggests a model involving a cationic pterin
Under conditions of reduced H4B availability, there isradical in the catalytic cycle.
strong evidence for superoxide generation by eNOS
(VaÂ squez-Vivar et al., 1998) leading to potential patho-
Introduction physiology. Furthermore, endothelial dysfunction is re-
versed in hypercholesterolemic patients treated with
Nitric oxide (NO), a free radical, is a ubiquitous signaling H4B and has been shown to be a NOS-related action
molecule that participates in diverse cellular processes, (Stroes et al., 1997). The availability of pterin-free struc-
including regulation of blood pressure, neurotransmis- ture can shed light on the molecular basis of superoxide
sion, and the immune response (Dinerman et al., 1993). generation by dysfunctional eNOS in H4B-depleted states.
NO is produced by nitric oxide synthases (NOS), which Recently, Crane et al. have reported the crystal struc-
consist of a heme domain linked via a calmodulin binding tures of the iNOS oxygenase domain monomer (1997)
linker peptide to a NADPH-cytochrome P450 reductase- and H4B-bound dimer (1998). The iNOS monomer is both
catalytically inactive and unable to bind either the sub-like diflavin domain, resulting in a large polypeptide (Mr
strate or H4B (Ghosh et al., 1997). Only the dimer is130,000±160,000). Only dimeric NOS is catalytically ac-
physiologically relevant and retains the ability to bindtive. Upon Ca21/calmodulin binding, the FAD of the fla-
substrate and cofactor, H4B. Crane et al. (1998) havevoprotein domain transfers reducing equivalents from
compared the crystal structures of the inactive iNOSNADPH to FMN, which then reduces the heme iron.
monomer and the H4B-bound dimer and conclude thatReduction of the heme iron leads to O2 activation fol-
pterin binding (a) is critical for dimer formation; (b)lowed by oxidation of an L-Arg guanidino N atom to NO
results in major conformational changes; (c) createsand L-citrulline (Marletta, 1994).
both the active-center channel and L-Arg-binding site;NOS constitute a family of enzymes of which three
and (d) leads to the formation of both reductase andgenetically encoded isoforms have been identified in
caveolin-binding sites. Here, we have addressed pterinmammalian systems (Knowles and Moncada, 1994;
function in NOS by determining the high-resolution crys-
tal structure of the dimeric eNOS heme domain both
alone and in complex with H4B. By a direct comparison§ To whom correspondence should be addressed (e-mail: poulos@
of the dimeric pterin-free and -bound eNOS heme do-uci.edu [T. L. P.], masters@uthscsa.edu [B. S. S. M.]).
‖ These authors contributed equally to this work. main structures we show that pterin binding (1) is not
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Figure 1. Tertiary Topology, Quaternary Structure, and Docking Surface of eNOS Heme Domain
(A) Ribbon diagram of the eNOS heme domain dimer (1H4B, 1SEITU data). The two H4B molecules are shown as yellow space-filled models.
The zinc located along the dyad axis of symmetry is highlighted as a red sphere. (B) Molecular surface map of the electrostatic potential of
the eNOS heme domain dimer calculated using GRASP (Nicholls et al., 1993). The blue and red contours represent positive and negative
potential (full saturation 5 16 kT), respectively. This view is rotated 908 from the orientation shown in (A) such that the viewer is looking toward
the ZnS4 center directly along the two-fold relating the monomers. The complementary electrostatic surface potential of the eNOS heme
domain and the FMN domain of the P450 reductase (Wang et al., 1997) depicts the proposed docking site between the two proteins.
required for dimer formation, (2) fails to produce confor- lower resolution (2.6 AÊ ) mouse iNOS dimer structure
(Crane et al., 1998). A novel feature of the eNOS structuremational changes either at the H4B site or anywhere
else in the protein, (3) neither affects substrate, L-Arg, that was not observed in the iNOS structure is the pres-
ence of a Zn ion tetrahedrally coordinated to pairs ofbinding, nor is required for the creation of the active
site/channel, and (4) does not elicit structural changes at symmetry-related Cys residues (Figures 1 and 2). Crane
et al. (1998) interpreted this region in iNOS as an inter-the proposed reductase and caveolin interaction sites.
Further, Crane et al. (1998) identified a disulfide bridge subunit disulfide bond between symmetry-related Cys-
109 residues that correspond to one of the ligands inat the bottom of the dimer interface involving a pair of
cysteine residues, one from each monomer. We unam- eNOS, Cys-101. They also noted a disordering in resi-
dues 101±107 immediately preceding Cys-109. This ap-biguously establish that these evolutionarily conserved
cysteines are involved in coordinating a zinc atom that parent discrepancy between the two structures could
be explained by a comparison of the proteins used infunctions both to stabilize the H4B-binding site and to
facilitate stereospecific pterin recognition. structure determination. Crane et al. (1998) obtained the
iNOS oxygenase domain by independently expressingHere, we present a high-resolution crystal structure
of a constitutive NOS (eNOS) heme domain both alone it in Escherichia coli, whereas the eNOS heme domain
used in this study was derived via trypsinolysis of theand in complex with H4B. The similarity between the
pterin-binding site in NOS and other pterin-utilizing en- holoenzyme (containing both heme and reductase do-
mains in a single polypeptide chain). NOS heme domainszymes indicates a catalytic role for H4B. We also provide
structural evidence for the ability of the substrate, L-Arg, expressed per se have a tendency not to incorporate
the metal ion (R. T. Miller and B. S. S. M., unpublishedto bind at the H4B site. The cofactor mimicry by the
substrate suggests a mechanism that directly implicates data). In the absence of the metal, due to the close
structural proximity of the sulfhydryls, a disulfide bondthe participation of a pterin radical cation in the catalytic
cycle leading to NO biosynthesis. Further, the pterin-free can form in vitro. However, considering the strongly
reducing conditions in the cytosol, the formation of adimer structure provides a molecular proving ground
for understanding the dysfunctional eNOS generated in disulfide would be both kinetically and thermodynami-
cally disfavored (Schwabe and Klug, 1994). Hence, theH4B-depleted pathological states.
loss of zinc in the iNOS structure most likely led to
the disordering of the polypeptide chain in this region.Results and Discussion
Owing to the strict conservation of the Cys-(X)4-Cys mo-
tif (Figure 3) in all NOS sequences known to date, theStructure and Conformation of the eNOS
Heme Domain zinc center is expected to be a common feature of all
NO synthases.The eNOS heme domain (Figure 1) belongs to the a/b
protein class, and the quaternary structure is character-
ized by a tightly packed dimer interface that buries 3000 Role of ZnS4 in Pterin Binding
and Reductase DockingAÊ 2 (per subunit) of solvent-accessible surface (55% hy-
drophobic and 45% polar). The overall fold of the eNOS The zinc tetrathiolate, ZnS4 or (Zn[S-cysteine]4)2-, metal
center in eNOS is located at the bottom of the dimerheme domain dimer is similar to that reported for the
Molecular Basis for Pterin Function in NOS
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Figure 2. ZnS4 Center at the Dimer Interface of eNOS Heme Domain
(A) Stereo view of the 2Fo2Fc 1.9 AÊ omit electron density map around the zinc metal center (1H4B, 1SEITU data). The map was obtained
from model phases after a round of simulated annealing with the atoms shown excluded from the refinement. The map is contoured at 1 s
(blue) and 10 s (black). The zinc ion was identified using anomalous dispersion effects characteristics for the metal. X-ray wavelengths of
1.280 AÊ and 1.286 AÊ (zinc absorption edge, l 5 1.283 AÊ ) were chosen using a tunable synchrotron X-ray source. Zinc exhibits significant
anomalous scattering effects at 1.280 AÊ with little anomalous scattering contribution at 1.286 AÊ . Heme Fe exhibits some anomalous scattering
at both wavelengths (iron absorption edge, l 5 1.739 AÊ ). Direct methods (Sheldrick, 1997) also were used to independently identify the
anomalous scatterers.
(B) The ZnS4 metal center and its relationship to H4B. Ser-104 is part of the loop containing the cysteine ligands and H-bonds to the C6 side
chain of pterin. The stereospecific recognition of H4B by NOS is dictated by the substitution at the C6 position.
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zinc ligands in NOS (Chen et al., 1995; Ghosh et al.,
1997; Miller et al., 1997; RodrõÂguez-Crespo et al., 1997).
ZnS4 centers have been observed in only four other
enzymes (Vallee and Auld, 1993; Lipscomb and StraÈ ter,
1996), including cytochrome oxidase (Tsukihara et al.,
1995) and Bacillus stearothermophilus adenylate kinase
(Berry and Phillips, 1998), where they play a structural
role. eNOS presents a unique scenario in which the ZnS4
center is sandwiched at the dimer interface in the vicinity
of the pterin-binding site. The metal center acts in a
structural capacity by helping to maintain the integrity of
the pterin-binding site. Furthermore, the most extensive
electropositive region on eNOS surrounds the ZnS4 cen-
ter (Figure 1B). This surface can provide an excellent
docking site for the strongly electronegative reductase
domain. This would also enable the electron donor (FMN
domain) to be in spatial proximity to the ZnS4 center.
The apparent requirement of the reductase domain for
the proper insertion of the metal center, as demon-
strated by the derivation of the heme domain dimer from
the holoenzyme constructs in these studies, argues in
favor of the close proximity between the ZnS4 and the
reductase domain. Both the zinc atom and its ligands
Figure 3. Sequence Alignments Depicting the Zinc-Binding Motif in are accessible to solvent in the heme domain structure
NOS and could have limited access in the holo-protein in
The strict conservation of the cysteine ligands in NOS utilized in which the FMN domain would be docked in the metal
coordinating the zinc atom are shown. Within the Cys-(X)4-Cys mo- center's vicinity. Interestingly, both Mss4 (Yu and Schrei-
tif, -(X)4- exhibits a preferential bias toward hydroxylated (Ser and ber, 1996) and LIM (Schmeichel and Beckerle, 1994)Thr) and charged (Arg, His, and Lys) residues.
proteins utilize ZnS4-containing surfaces to mediate pro-
tein±protein interactions, and a similar function could
interface (Figure 1A) with the metal tetrahedrally coordi- be envisioned for the metal center in NOS enzymes as
nated by two pairs of symmetry-related cysteine resi- well.
dues (Figure 2, Cys-96 and Cys-101) from each subunit. Crane et al. (1998) proposed a docking site that in-
The cysteine ligands are part of a small three-stranded cludes Trp-366 of iNOS oxygenase domain for interac-
antiparallel b sheet (two strands from one monomer and tion with the reductase and caveolin-1. They also sug-
one strand from the other) that orients Cys-96 and Cys- gest that this region undergoes a conformational change
101 in the same direction directly across antiparallel upon pterin binding to facilitate docking. Since eNOS,
strands. In addition to the b strand main chain H-bonds, and not iNOS, is targeted to the caveolae (Shaul et al.,
Sg (96) and Sg (101) form H-bonds with the peptide NH 1996), it was of interest to examine this site for its abil-
residues Leu-102 and Gly-103, respectively. Also, the ity to dock with caveolin (GarcõÂa-CardenÄ a et al., 1997).
amide N of Cys-101 is H-bonded to the .C5O of Asn- The proposed recognition motif for caveolin-1 in eNOS,
468. This H-bonding pattern differs from that observed in Phe-(X)4-Phe-(X)2-Trp (Couet et al., 1997), is primarily
the rubredoxin ªknuckle-motifº (Cys-(X)2-Cys) (Schwabe solvent inaccessible (using a 1.4 AÊ probe) exposing only
and Klug, 1994), where each cysteine side chain Sg (i) the indole ring of the terminal Trp-358. In addition, since
forms an H-bond with the backbone amide of the i 1 2 neither pterin-free nor -bound structures show any dif-
residue. However, the extensive H-bond network is in ference in this region, the ability of the proposed re-
large part due to the formal negative charge on the sulfur gion to support caveolin and reductase recognition is
ligands. H-bonds between sulfur ligands and amide NH suspect.
groups are a signature of metal sulfur centers. The identification of ZnS4 in eNOS has physiological
The zinc is positioned equidistant from each heme relevance. If one or more cysteine ligands could remain
(21.6 AÊ ) and H4B (12 AÊ ) with one of its ligands, Cys-101, nucleophilic, it would be possible for the cysteine li-
separated only by two residues from Ser-104, which gand(s) to undergo S-nitrosylation (Stamler, 1994) fol-
H-bonds directly to the pterin side chain hydroxyl (Figure lowed by the ejection of zinc. The DNA repair enzyme,
2B). In addition, Val-106 forms a direct nonbonded con- Escherichia coli Ada, provides a known example where
tact with H4B. Therefore, disruption of the metal center the nucleophilicity of the cysteine coordinated to zinc
either by demetallation or ligand removal via mutagene- (ZnS4) is preserved (Wilker and Lippard, 1995) and uti-
sis will distort this region of the polypeptide chain re- lized in catalysis. The release of zinc may also be con-
sulting in diminished affinity for H4B. Since H4B couples trolled by the redox status in situ (Maret and Vallee,
directly to the heme, alterations at the pterin site will in 1998). NO can release zinc from ZnS4 clusters of proteins
turn affect the heme pocket and L-Arg binding. These (Gergel and Cederbaum, 1996), including transcription
structural findings help explain why a large body of mu- factors and NOS (R. T. Miller and B. S. S. M., unpublished
tational data shows dramatic loss in protein stability, observations), and it remains to be established whether
nitrosative stress in vivo can regulate NO biosynthesis.catalytic activity, and H4B binding upon removal of the
Molecular Basis for Pterin Function in NOS
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Figure 4. Hydrogen Bond Networks at the
H4B-Binding Site
Given the zinc requirement for endothelial function, it is loop involved in zinc ligation (Figure 2B), emphasizes the
importance of the zinc center in ensuring stereospecificconceivable that acquired vascular dysfunction can be
recognition of H4B.associated with mutations that weaken zinc affinity re-
A comparison of the H4B binding mode in eNOS withsulting in dysfunctional eNOS. While no such mutations
other enzymes that either utilize pterin as a substrateare known at present, a parallel can be drawn from
or cofactor reveals insights into pterin function in NOfamilial amyotropic lateral sclerosis, in which over 50
biosynthesis. First, the recognition of the H4B pyrima-independent variants in Cu/Zn-superoxide dismutase
done by the heme propionate in eNOS is comparablegive rise to a common toxic phenotype invariably char-
to the use of Asp or Glu residues by other pterin en-acterized by decreased zinc affinity (up to 100,000-fold;
zymes. For example, an acidic residue always formsCrow et al., 1997).
bifurcated H-bonds via its carboxylate function with the
N-2 and N-3 nitrogens of the pterin substrate (AuerbachStructural Determinants for H4B Binding and Its
et al., 1997). In addition, dihydrofolate reductase (DHFR;Relationship to the Pterin Family of Enzymes
McTigue et al., 1993), dihydroneopterin aldolase (HennigThe high-resolution structure of the pterin-bound eNOS
et al., 1998), dihydropteroate synthase (DHPS; Hampeleheme domain facilitates not only a quantitative analysis
et al., 1997), thymidylate synthase (TS; Birdsall et al.,of the H4B±protein interactions, but also addresses the
1996), and the molybdopterin oxidoreductase (Chan etstereospecificity of cofactor recognition via the newly
al., 1995) all utilize a carboxylate to interact with theidentified ZnS4 center. The extensive H-bond network pterin. Second, the pterin recognition in NOS is reminis-involving pterin and eNOS (Figure 4) attests to the cofac-
cent of the GTP-binding motif of the GTPase superfamily
tor's unusually high affinity (Kd 20 nM; Werner-Felmayer of proteins, which provide an archetypal protein carbox-
and Gross, 1996). NOS enzymes have a preference for ylate for interacting with the pyrimadone moiety (Bourne
the fully reduced (R) stereoisomer of H4B with the (S) et al., 1991). Thus, NOS has evolved to retain a carboxyl-
isomer binding weakly and less effective in sustaining ate for mediating pterin recognition, but unlike the
catalysis (Presta et al., 1998). The H-bond network in GTPase superfamily, it utilizes a propionate of the heme
eNOS aids in understanding the structural basis for the prosthetic group. Third, the aromatic stacking of the
favored chiral centers at C6, C1', and C2' of H4B (Figure pterin in eNOS (Figures 4 and 5A) is surprisingly similar
4). The molecular recognition of H4B is mediated by one to that seen in the ricin±neopterin complex (Yan et al.,
of the heme propionate groups in which a carboxylate 1997) and in TS (Birdsall et al., 1996).
oxygen H-bonds directly with the pyrimadone moiety While the similarities between H4B recognition in NOS
(N-3 and the amine at C-2) of the pterin. The same propi- and other pterin-utilizing enzymes are striking, the differ-
onate is also H-bonded to the amino group of the sub- ences provide clues to why NO biosynthesis requires
strate L-Arg. The other carboxylate oxygen establishes pterin as a cofactor. Only in NOS, DHPS, and ricin is a
a water-bridged H-bond with the 4-keto group. Arg-367 positively charged residue positioned within H-bonding
also makes a direct H-bond to this group. Another key distance to the 4-keto group of the pteridine ring. In all
interaction in H4B recognition involves Ser-104, which other cases a main chain amide acts as the H-bond
H-bonds to the dihydroxypropyl side chain and helps donor. Pteridine dehydratase (DCoH; Cronk et al., 1996),
tyrosine hydroxylase (TyrOH; Goodwill et al., 1998), andorient it. The strategic location of Ser-104, as part of a
Cell
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Figure 5. Cooperativity and Molecular Mimicry in eNOS
(A) Cross talk between H4B and L-Arg mediated by the heme propionate (Se-edge data). The guanidinium and amino groups of L-Arg are held
in place by H-bonding with the conserved Glu-363. The amino group also H-bonds with a heme propionate. H4B H-bonds directly with the
heme propionate, while the pteridine ring is sandwiched between Phe-462 in one monomer and Trp-449 in another, respectively.
(B) L-Arg is a structural mimic of H4B at the pterin-binding site when SEITU is bound at the active site (-H4B, 1SEITU data). L-Arg binds to
the pterin site and exquisitely mimics the H4B interaction with eNOS ([A] and Figure 4). The specific interaction of the potent inhibitor, SEITU,
at the active site is mediated by a pair of bifurcated H-bonds to Glu-363. Two water molecules bridge between the inhibitor and heme
propionate. The ethyl group of the inhibitor forms nonbonded contacts with Val-338 and Phe-355. The ureido sulfur is positioned 3.5 AÊ and
4.0 AÊ above heme pyrrole B-ring nitrogen and the heme iron, respectively.
dihydropteridine reductase (DHPR; Varughese et al., Three major conclusions stem from the structural dis-
1992) incorporate the most significant differences in section of the pterin site in eNOS. First, H4B ↔ qH2B
pterin recognition when compared to NOS and other cycling, observed in AAH catalysis, can be ruled out in
pterin enzymes. In sharp contrast to eNOS, neither NOS, since the highly activated pyrimidine nucleus of
TyrOH nor DCoH, which use H4B as a cofactor and sub- H4B is adequately protected by H-bonds. In addition,
strate, respectively, involves direct protein interaction the non±heme iron center, a sine qua non for catalysis
with N-3 of the pterin. This is because the catalytic in AAH, is absent in eNOS. These observations provide
step in both enzymes involves oxidation/reduction at the a structural basis for understanding why oxidation prod-
pyrimidine portion of the pterin ring. qH2B recognition by ucts of pterin have not been observed during NOS catal-
DHPR appears to adopt a similar mode of interaction ysis (Tayeh and Marletta, 1989). In this regard, NOS
as well (Varughese et al., 1992). The pterin-binding site resembles enzymes that utilize tetrahydrofolate as co-
in TyrOH and DHPR also is accessible to solvent such factors without taking advantage of redox properties
that the product can be easily released toward regenera- of the H4B ring system (Matthews, 1982). Second, an
tion of the substrate. In NOS, H4B is tied down by numer- inherent DHPR-like activity (Witteveen et al., 1996) can
ous H-bonded and water-bridged interactions to pre- also be ruled out since structural comparisons between
vent facile release into the solvent (Figure 4). This is in the pterin site in eNOS and DHPR (Varughese et al., 1992)
excellent agreement with the three orders of magnitude fail to reveal similarities. Third, the H4B-binding site of
(Werner-Felmayer and Gross, 1996) greater affinity for eNOS strongly resembles the catalytic site of enzymes
H4B of NOS compared to TyrOH. Furthermore, a tightly that utilize pterin as a substrate. Thus, H4B directly par-
held glycerol molecule occupies the space above the ticipates in catalysis and undergoes a chemical re-
4a position of H4B in eNOS. Glycerol is a leftover from arrangement unlike either AAH or pteridine reductase.
protein purification. In its absence, solvent molecules
are expected to fill this region. Perry and Marletta (1998)
Pterin-Free Structure, Molecular Mimicry,recently suggested that NOS resembles the aromatic
and Structural Basis for H4Bamino acid hydroxylases (AAH) with respect to pterin
Substrate Cooperativityfunction. Unlike the TyrOH case (Goodwill et al., 1998),
There is an ongoing debate regarding the function ofa non±heme iron center, which directly participates in
pterin in NOS structure and catalysis (Hyun et al.,catalysis, is absent within a 5.6 AÊ distance of the 4a
1995; Hemmens and Mayer, 1997; Perry and Marletta,position of H4B in eNOS. This region in eNOS is also
1998). Recently, Crane et al. (1998) compared the struc-devoid of multiple ligands to sustain metal ligation. In
ture of an inactive iNOS oxygenase domain monomeraddition, cocrystallization in the presence of FeSO4 (10
with a H4B-bound dimer structure. They concluded thatmM) failed to reveal metal binding (via anomalous scat-
pterin binding was critical for dimer formation. Theytering) in the vicinity of the 4a position of H4B. Thus, the
further suggested that pterin binding results in a majormechanism of pterin function in NOS has no discernible
similarities to TyrOH, DCoH, or DHPR. conformational change leading to active site/channel
Molecular Basis for Pterin Function in NOS
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Figure 6. Pterin-Free Structures of eNOS
(A) 2Fo2Fc 2.1 AÊ omit electron density map showing L-Arg bound at the pterin-binding site (-H4B, 1SEITU data).
(B) 2Fo2Fc 1.95 AÊ omit electron density map illustrating the empty pterin-binding site occupied only by solvent molecules (-H4B, 1Arg data).
A glycerol molecule has been modeled to account for the residual density.
formation and controls the generation of the reductase pterin and active sites preexist and do not form via
conformational changes or induced fit resulting fromand caveolin docking sites. It is important to note, how-
ever, that the iNOS monomer used in the crystal struc- ligand binding, as suggested by Crane et al. (1998).
The 1.95 AÊ pterin-free structure (Figure 6B) also holdsture work (Crane et al., 1997) was missing the first 114
residues essential for dimerization and zinc binding. The clues to explain why under conditions of limited H4B
availability, eNOS and, in particular, the heme domainiNOS monomer is also catalytically incompetent due to
its inability to bind both substrate and cofactor (Ghosh produce the deleterious superoxide radical (VaÂ squez-
Vivar et al., 1998). This is of considerable physiologicet al., 1997). As a result, functionally important compari-
sons between the iNOS monomer and dimer structures interest since H4B depletion is associated with vascular
pathology (Cosentino et al., 1998). Supplementation withcannot be made. In an effort to identify the true function
of pterin in NOS structure and catalysis, we have solved H4B, however, totally couples L-Arg oxidation to NO
synthesis, and superoxide generation is prevented. Sincethe structure of eNOS heme domain dimer, both in the
H4B-free and -bound states. The eNOS protein used in there are no major structural changes at the active or
H4B sites in pterin-free eNOS (rmsd , 0.3 AÊ ), lack ofthis study was obtained via expression in Escherichia
coli, which inherently lacks the machinery to synthesize occupancy at the pterin site with precise orientational
constraints must be the basis for superoxide production.H4B. The protein is dimeric (MartaÂ sek et al., 1996; Ven-
ema et al., 1997) even in the total absence of pterin and The substrate is able to bind in the absence of pterin,
but it is unable to prevent superoxide production, thusretains the ability to readily bind substrate and H4B.
In the absence of H4B, the overall eNOS heme domain implicating H4B in controlling the latter. The uncoupling
of L-Arg oxidation to NADPH consumption due to thestructure remains unchanged both in tertiary topology
and quaternary structure. Comparison of the pterin- lack of H4B probably leads to electron transfer to molec-
ular oxygen, resulting in superoxide production. Thebound (Figure 5A) and -free (Figure 6B) structures re-
veals that the H4B site preexists in eNOS. Furthermore, eNOS±H4B interaction is reminiscent of the need for
proper positioning of the flavin isoalloxazine cofactor,it is possible to soak H4B into pterin-free eNOS heme
domain crystals without disturbing the crystal lattice. during turnover, for total coupling in the catalysis of
p-hydroxybenzoate hydroxylase (Gatti et al., 1994).Both the substrate channel and the active site are unaf-
fected by the lack of pterin at the H4B-binding site. In The pterin-free eNOS structure with a potent inhibitor,
S-ethylisothiourea (SEITU; Kd 30 nM, Garvey et al., 1994),fact, the mode of L-Arg binding at the active site in the
pterin-free structure of eNOS is identical to that seen in bound at the substrate site (Figure 5B), reveals a surpris-
ing result. The pterin site is no longer empty and isthe H4B-bound structure (data not shown). There also
is biochemical evidence for substrate analog (Nv-nitro- now occupied by the substrate, L-arginine. The mode
of L±Arg interaction at the pterin site (Figures 5B andL-arginine) recognition by eNOS even in the absence of
H4B (MartaÂ sek et al., 1996). The neuronal (Roman et al., 6A) mimics that entertained by H4B itself (Figure 5A).
Two critical H-bonds with L-arginine, one between a1995) isoform, however, shows a strict prerequisite for
H4B to facilitate Nv-nitro-L-arginine binding. Since the guanidino N and the heme propionate, and another
involving the primary amino group and Ser-104 areheme propionate is a common denominator for both
substrate and H4B recognition (Figure 5A), the coopera- strictly conserved (Figure 6A). Moreover, the planar gua-
nidinium group is sandwiched between two aromatictivity between the two sites may be mediated by strin-
gent positioning of the heme propionate. Thus, both the groups, one from each monomer, exactly as in the H4B
Cell
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complex. The affinity for L-Arg must be significant, since
no exogenous L-Arg was added during crystallization
and only 200 mM of the substrate was carried over from
protein purification. The specificity of L-Arg recognition
at the pterin site appears to require both the guanidino
function and the primary amino group since SEITU (5
mM used in cocrystallization) was unable to displace
L-Arg from the pterin site. The existence of cooperativity
between the substrate and H4B sites is further high-
lighted by the discovery that L-Arg can occupy the pterin
site when a strong inhibitor is bound at the active site.
It is puzzling that L-Arg occupies the pterin site only
when SEITU is bound at the active site and not when
the substrate occupies the latter site. Alderton et al.
(1998) have provided empirical evidence for the ability
of SEITU to promote pterin binding. Thus, the inhibitor-
bound conformation may facilitate L-Arg binding at the
pterin site, owing to the strong structural similarity be-
tween the substrate and pterin.
It is conceivable that the H4B site possibly evolved
Figure 7. Proposed Mechanism for Pterin in NO Biosynthesisfrom what was originally an L-Arg-binding site and may
The uniqueness of the H4B±eNOS interaction (Figure 4) and theprovide clues toward understanding the primordial NOS
ability to bind L-Arg at the pterin site present a strong case forcatalytic machinery. Furthermore, the higher affinity of
the involvement of a pterin radical in NOS catalysis and rule outNOS for H4B may have evolved to repel competition the possibility of H4B ↔ qH2B cycling during NO biosynthesis. Rfrom L-Arg, which is abundant in cells (0.2±0.8 mM; represents the dihydroxypropyl side chain at the C6 position on the
Hecker et al., 1992). A striking corollary can be estab- pterin ring.
lished between our finding and the ability of Tetrahy-
mena group I catalytic RNA to specifically recognize
L-Arg as a competitive inhibitor and mimic for guanosine TS and ricin), but resonance stabilization of the semi-
quinone radical found in flavoproteins are mediatedbinding (Yarus 1988).
through stacking interactions. The cation±p interactions
are strong and specific (Dougherty, 1996), and H4B cat-
Implications for the Role of Pterin Radical ion-p interactions with W449 and F462 may play a key
in NOS Catalysis role in the molecular recognition of pterin by eNOS.
The elegant mimicry of the obligatory H4B cofactor by NOS provides an example where an enzyme may have
L-Arg provides mechanistic insights into the role played evolved to accommodate a pterin function to mimic fla-
by pterin in NOS catalysis. The specific recognition of voprotein systems in structure and mechanism.
L-Arg at the H4B site (Figure 6A) in eNOS suggests the
ability of this site to stabilize a positively charged state of Experimental Procedures
the pterin ring and, particularly, the pterin cation radical
Expression, Purification, and Crystallization(Figure 7). In order for NOS to utilize a pterin radical,
of eNOS Heme Domainextensive protonation of the bound H4B is necessary. Bovine eNOS heme domain (39±482; Mr 49,000) was obtained via
L-Arg binding to the pterin site argues in favor of the trypsinolysis of a holo eNOS construct missing 75% of the calmodu-
H4B site to recognize a fully protonated pterin. The stabi- lin-binding region. The expression of eNOS in Escherichia coli and
protein purification methods have been described previously (Mar-lization of the pterin radical does not stem from the
taÂ sek et al., 1996). Crystals suitable for diffraction were grown byprotonation, per se, but from the ability to restrict the
the sitting drop vapor-diffusion method from 15% PEG 3350, 200lone pair on N-5 of the pterin ring (Kappock and Cara-
mM magnesium acetate, 100 mM sodium cacodylate (pH 6.5), anddonna, 1996). Cycling between the pterin radical and
1 mM SEITU (or 5 mM L-Arg) in the presence of 35 mM sodium
H4B may be achieved via electron transfer from the re- dodecyl sulfate (SDS) as an additive and 5 mM Tris(2-carboxyeth-
ductase domain while the pterin remains bound to NOS. yl)phosphine (TCEP) or 5 mM glutathione sulfonate as reducing
agent. Crystals grown under these conditions belong to the ortho-The results have already alluded to the possibility of
rhombic space group, P212121, with cell constants a 5 58.00 AÊ , b 5docking the reductase (FMN) domain in the vicinity of
106.55 AÊ , and c 5 156.22 AÊ . There is one dimer in the asymmetricthe zinc center and pterin site, which could facilitate
unit (50% solvent content). All native and derivative crystals werethe one-electron reduction of the pterin radical to H4B. flash frozen in liquid nitrogen for both storage and data collection
Based on rapid reaction kinetics, a pterin radical has at cryogenic temperatures (100 K). A protein stabilization cocktail
been proposed in nNOS (Bec et al., 1998), and the eNOS containing 15% glycerol, 11% trehalose, 8% mannitol, and 8% su-
crose was used as cryoprotectant.heme domain structure lends mechanistic support for
its involvement in the catalysis. Also, evidence for a
Structure Determination and Refinementprotein-bound pterin radical species in aldehyde dehy-
Table 1 provides a summary of data collection statistics, phasedrogenase was recently provided via EPR spectroscopy
determination, and structure refinement. Data were collected with
(Luykx et al., 1998). Further, aromatic stacking is not a a charge coupled device (CCD) detector at ALS, CHESS, NSLS, and
common feature in binding sites of other pterin-utilizing SSRL (beamlines 5.0.2, F1 and F2, X12B, and 1±5, respectively) and
with a Mar Research image plate scanner at SSRL (beamlines 7±1enzymes (Auerbach et al., 1997; with the exception of
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Table 1. Data Collection, Phasing, and Refinement Statistics
Data Collection
1H4B, 2H4B, 2H4B,
1SEITU 1SEITU 1Arg Se-edge Se-peak Se-remote Se-EMPa Se-OsO3(Py)2a
Wavelength (AÊ ) 0.9798 1.08 1.000 0.9801 0.9794 0.9252 1.08 1.08
Resolution limits (AÊ ) 1.9 2.1 1.95 2.3 2.3 2.3 2.3 3.0
Total observations 217,080 204,608 255,850 131,275 127,968 144,570 131,287 74,034
Unique observations 74,337 57,723 69,580 40,100 36,351 40,965 40,508 16,204
Rsym 0.044 0.084 0.054 0.048 0.054 0.044 0.059 0.085
Rsym (outer shell) 0.175 0.563 0.660 0.121 0.219 0.185 0.325 0.336
,I/s. 19.3 7.7 9.6 16.9 15.3 17.1 9.8 8.9
,I/s. (outer shell) 3.5 2.4 1.6 3.2 2.2 3.1 2.2 4.0
Completeness 0.965 0.996 0.983 0.962 0.988 0.985 0.977 0.808
Completeness (outer shell) 0.800 0.996 0.983 0.795 0.802 0.983 0.801 0.829
MAD phasing (20.0±2.35 AÊ )
No. of sites 6
Phasing power Iso/Ano 0.0/0.76 0.0/0.78 1.1/0.75
Rcullis Iso/Ano 0.0/0.96 0.97/0.96 0.41/0.95
MIRAS phasing
No. of sites 6 5
Riso 0.157 0.173
Rcullis 0.89 0.92
Phasing power Iso/Ano 1.15/0.87 0.71/0.85
Overall FOM (MAD1MIRAS) 0.29 (2.35 AÊ )
Refinement
Protein Rms
Resolution (AÊ ) Atoms Waters R Factor Rfree Reflections Deviationb
X-PLOR (1H4B,1SEITU) 30.0±1.9 6593 591 0.225 0.262 73,483
(F.2sF) (F.2sF)
SHELXL (1H4B, 1SEITU) 10.0±1.9 6593 591 0.207 0.278 70,029 0.007 AÊ , 0.021 AÊ
X-PLOR (2H4B, 1SEITU) 30.0±2.1 6593 336 0.197 0.252 48,347 0.007 AÊ ,
(F.2sF) (F.2sF) 1.4088
X-PLOR (2H4B, 1Arg) 30.0±1.95 6593 402 0.212 0.260 56,572 0.008 AÊ ,
(F.2sF) (F.2sF) 1.4738
Rsym 5 S|I 2,I.|/SI, where I is the observed intensity and ,I. the average intensity of multiple symmetry-related observations of that
reflection. Riso 5 S|FPH 2 FP|/S FP. Rcullis Iso (acentric) 5 rms lack of closure/rms isomorphous difference (statistics from SHARP). Rcullis Ano 5
rms lack of closure/rms anomalous difference (statistics from SHARP). Phasing power 5 rms heavy atom structure factor/phase-integrated
lack of closure (statistics from SHARP). Overall FOM, overall figure of merit (from SHARP). Rfree 5 R factor calculated using 5% (3685 reflections)
of the reflection data chosen randomly and set aside from the start of the refinement.
a EMP, ethyl mercuric phosphate. OsO3Py2, osmium bis-pyridine; heavy atom derivatives were prepared with crystals generated by cocrystalliza-
tion with the Se inhibitor.
b Rms deviations are defined as bond length and angular distances in SHELXL and bond length and bond angle, respectively, in X-PLOR.
(1H4B, 1SEITU), structure with H4B bound at the pterin site and SEITU bound at the active site; (2H4B, 1SEITU), H4B-free structure with
L-Arg bound at the pterin site and SEITU bound at the active site; (2H4B, 1Arg), H4B-free structure with L-Arg bound at the active site; Se-
edge, structure with H4B bound at the pterin site and L-Arg bound at the active site.
and 9±1). Multiwavelength anomalous diffraction (MAD) data were six sites initially assigned to selenium are most likely adducts of
(CH3)2As to both Cys-384 residues (one per monomer) from thecollected at three wavelengths near the Se absorption edge using
the inverse beam mode after aligning the crystal with a major axis cacodylate buffer used in crystallization. Since the crystallization
solution contains excess reducing agents, we attribute this chemis-coincident with the rotation axis so that Bijvoet pairs could be mea-
sured simultaneously. Image plate data were reduced using the try (Barber, 1932) to the reduction of dimethylarsinate (V) to dimeth-
ylarsonite (III) followed by reaction with Cys-384. The three remain-programs DENZO and SCALEPACK (Otwinoski and Minor, 1997),
and CCD data were processed with the DPS (Steller et al., 1997), ing sites initially thought to be selenium, two near both Cys-214
sulfurs and one near Cys-87, were much weaker and could not beMOSFLM, and CCP4 suite of programs (Collaborative Computa-
tional Project No. 4, 1994). Mercury and osmium positions (three confidently modeled as (CH3)2As sites in the final refined electron
density map. Despite the incorrect assignment of the arsenic andsites each) were readily identified by SHELXS (Sheldrick, 1997) and
could later be confirmed in the isomorphous and anomalous differ- zinc sites as selenium, their inclusion was essential for obtaining
an interpretable electron density map. Availability of heme iron posi-ence Patterson maps. Iterative rounds of rejections performed with
ENDHKL (Louis Sanchez, Cal. Tech.) in conjunction with SCALE- tions, identified independently via anomalous scattering at the Fe
edge, greatly facilitated the location of heavy atom sites. HeavyPACK (Otwinoski and Minor, 1997) and local scaling were both criti-
cal for the identification of the heavy atoms. For MAD phasing an atom derivative screening was carried out with PHASES (Furey and
Swaminathan, 1997) and visualized using XTALVIEW (McRee, 1993).inhibitor, S-(2- (5 ( (amidinothio)methyl) -2-thienyl)ethyl) isothiourea
(Garvey et al., 1994), was prepared with the sulfur atoms replaced The final combined MAD and heavy atom refinement was done with
SHARP (de La Fortelle and Bricogne, 1997) followed by densitywith selenium. Once the structure was refined, it was evident that
the inhibitor had not bound. Three out of six sites initially assigned modification with either SOLOMON (Abrahams and Leslie, 1996) or
DM. The latter calculation includes noncrystallographic symmetryto selenium were the new zinc site and two arsenic sites. Both atom
types, Zn and As, were confirmed via a thorough analysis of Bijovet (NCS) averaging. The resulting experimental MAD-heavy atom deriv-
ative map at 2.35 AÊ was of sufficient quality to allow nearly all thedifference Fourier calculations at multiple wavelengths. Two of the
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main chain atoms and 80% of the side chain atoms to be built into Birdsall, D.L., Finer-Moore, J., and Stroud, R.M. (1996). Entropy in bi-
substrate enzymes: proposed role of an alternate site in chaperoningthe model before the first round of refinement. Phase refinement
substrate into, and products out of, thymidylate synthase. J. Mol.with heavy atom data alone did not produce an interpretable map.
Biol. 255, 522±535.Heme iron positions, SHELXS, MAD phasing, SHARP, and synchro-
tron radiation were a sine qua non for success in the structure Bourne, H.R., Sanders, D.A., and McCormick, F. (1991). The GTPase
solution. Structural refinement was performed with XPLOR (BruÈ nger, superfamily: conserved structure and molecular mechanism. Nature
1992) and SHELXL (Sheldrick and Schneider, 1997). Five percent of 349, 117±127.
the data were set aside for free-R cross validation prior to any BruÈ nger, A.T. (1992). X-PLOR version 3.1: a system for X-ray crystal-
structural refinement. The protein model was built using TOM and lography and NMR. (New Haven, CT: Yale University Press).
improved with SigmaA-weighted 2|Fobs| 2 |Fcalc| and |Fobs| 2 |Fcalc| Collaborative Computational Project, Number 4. (1994). The CCP4maps iteratively with X-PLOR refinement. A bulk solvent correction
suite: programs for protein crystallography. Acta Crystallogr. D50,was used in the final stages of the X-PLOR but not in the SHELXL
760±763.refinement. The current model at 1.9 AÊ resolution includes 830 resi-
Chan, M.K., Mukund, S., Kletzin, A., Adams, M.W., and Rees, D.C.dues (residues 67±482 in molecule A; 69±482 in molecule B) and
(1995). Structure of a hyperthermophilic tungstopterin enzyme, alde-591 waters. Residues 39±66 and 108±121 are disordered primarily
hyde ferredoxin oxidoreductase. Science 267, 1463±1469.due to the proline-rich nature of these regions. Ramachandran plots
Chen, P-F., Tsai, A-L., and Wu, K.K. (1995). Cysteine 99 of endothelialgenerated with PROCHECK showed that 90.2% of the residues were
nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-in the most favored regions and 9.6% were in additional allowed
dependent NOS-III stability and activity. Biochem. Biophys. Res.regions. Solvent-accessible surface area calculations were done
Commun. 215, 1119±1129.with MSP (Connolly, 1993).
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Coordinates have been deposited with the ID codes 1NSE, 2NSE,
3NSE, and 4NSE.
